You searched for Antibody candidate - Page 22 of 69

News and Trends 11 Jun 2020

AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal

…sales milestones. The two companies will jointly develop and commercialize three of Genmab’s anti-cancer antibody drugs, which are currently in phase I trials. Genmab’s antibody drugs — which are able…

June 11, 2020 - 3 minutesmins - By External Contributor

News and Trends 26 Feb 2016

A New Super-Antibody against Ebola has been Isolated

…seems unlikely that Humabs will be the first to approve a vaccine for Ebola. But this new antibody is a really promising candidate to treat people already infected. Feature image…

February 26, 2016 - 3 minutesmins - By Denise Neves Gameiro

abcam axiomx acquisition milestone antibody

More News! 18 May 2017

Abcam Makes Final Payment in the Acquisition of an US Antibody Biotech

Abcam has paid US-based AxioMx a final €4.5M milestone based on performance, completing an acquisition that totals €36.4M. Giant antibody maker Abcam, founded by star biotech entrepreneur Jonathan Milner and…

May 18, 2017 - 1 minutemin - By Clara Rodríguez Fernández

Regeneron Sanofi dupilumab Atopic Dermatitis

News and Trends 29 Mar 2017

Get Ready for One of the Biggest New Drug Approvals of the Year

…such as those implicated in atopic dermatitis, asthma and allergies. The antibody represents the first drug targeting the IL-4/IL-13 pathways. The antibody is indicated for the treatment of moderate to…

March 29, 2017 - 3 minutesmins - By Melanie De Almeida

Best in Biotech 30 Jun 2023

Five biotech companies making a name for themselves in Vancouver

…antibody therapy treatment for COVID-19, when, in 2021, bamlanivimab, used together with etesevimab, became the first monoclonal antibody medicine for COVID-19 to receive U.S. Food and Drug Administration (FDA) Emergency…

June 30, 2023 - 6 minutesmins - By Willow Shah-Neville

News and Trends 5 Oct 2022

Transcenta monoclonal antibody gets FDA clearance

Transcenta Holding Limited says its TST004 humanized monoclonal antibody targeting MASP2, has received IND clearance from the U.S. Food and Drug Administration (FDA). MASP2, mannose-binding protein-associated serine protease 2, is…

October 5, 2022 - 2 minutesmins - By Jim Cornall

Innate Pharma Cancer immunotherapy header

News and Trends 22 Oct 2018

Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold

…cancer patients that is very hard to treat. A checkpoint inhibitor antibody In the Phase II trial, Innate’s checkpoint inhibitor antibody was part of a combination therapy. While…

October 22, 2018 - 2 minutesmins - By Jonathan Smith

samsung bioepis imraldi humira adalimumab biosimilar tnf a

News and Trends 28 Aug 2017

Samsung Bioepis Gets European Approval for Biosimilar of Best-Selling Antibody

…anti-TNF-α antibody launched by Samsung Bioepis, making it the first company with biosimilars of all blockbusters that that target TNF-α. The other two are Benepali, a biosimilar of Amgen and…

August 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 21 Apr 2016

Llama Biotech makes €600M deal with AbbVie for Immuno-Oncology

…(another Belgian biotech) approaches antibody engineering, well known for its Camelidae mAbs. argenx has several propietary antibody platforms. The SIMPLE Antibody uses llama to…make Pharma. (Source: argenx) ARGX-115 is argenx’s…

April 21, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 4 Jul 2016

Danish Pharma enters in the Biologics arena with Antibody Buy-out

…AstraZeneca, that are significantly closer to the market. First, there is tralokinumab, which has completed Phase II trials for atopic dermatitis. The candidate is a monoclonal antibody and targets a…

July 4, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 10 Mar 2016

Antibody Start-up Gets a Slice of a Rebranded €210M Life Sciences Fund

Capella Biosciences (UK) is a life sciences start-up specializing in antibodies. It has just raised an additional €14.3M in a Series A round to develop their antibody pipeline to clinical…

March 10, 2016 - 2 minutesmins - By Denise Neves Gameiro

In Depth 30 May 2024

Covalent biologics: a new class of drugs on the horizon

…American company Enlaza Therapeutics’ undisclosed preclinical pipeline is mainly focused on antibody drug conjugates (ADCs). These drugs consist of an antibody that attaches to cancer cell targets, a chemotherapy drug…

May 30, 2024 - 6 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal

A New Super-Antibody against Ebola has been Isolated

Abcam Makes Final Payment in the Acquisition of an US Antibody Biotech

Get Ready for One of the Biggest New Drug Approvals of the Year

Five biotech companies making a name for themselves in Vancouver

Transcenta monoclonal antibody gets FDA clearance

Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold

Samsung Bioepis Gets European Approval for Biosimilar of Best-Selling Antibody

Llama Biotech makes €600M deal with AbbVie for Immuno-Oncology

Danish Pharma enters in the Biologics arena with Antibody Buy-out

Antibody Start-up Gets a Slice of a Rebranded €210M Life Sciences Fund

Covalent biologics: a new class of drugs on the horizon

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!